TH
Thermopylae Holdings Ltd. Other
US US · SEC (Form 4)
Explore the full record of transactions filed by Thermopylae Holdings Ltd.. Director active across 1 companies, notably AbCellera Biologics Inc.. In total, 8 reports have been recorded. Total volume traded: €237.7m. The latest transaction was disclosed on 13 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations 8 total
€423,485 54,915 shares @ €7.7117 0.034% mcap 0.2% of flow
Common Shares
SEC:0001209191-22-036884:0 · 13 Jun 2022
Ideal exit: 10 Mar 2023 (T+270) €452,667 64,545 shares @ €7.0132 0.036% mcap 0.2% of flow
Common Shares
SEC:0001209191-22-034983:0 · 6 Jun 2022
Ideal exit: 3 Mar 2023 (T+270) €2m 300,000 shares @ €6.9898 0.17% mcap 0.9% of flow
Common Shares
SEC:0001209191-22-029541:0 · 13 May 2022
Ideal exit: 7 Feb 2023 (T+270) €9m 1,408,468 shares @ €6.1712 0.70% mcap 3.7% of flow
Common Shares
SEC:0001209191-22-029092:0 · 12 May 2022
Ideal exit: 6 Feb 2023 (T+270) €3m 202,960 shares @ €12.8515 0.21% mcap 2.3% of flow
Common Shares
SEC:0001209191-21-064377 · 11 Nov 2021
Ideal exit: 8 Aug 2022 (T+270) €3m 202,960 shares @ €12.8515 0.21% mcap 1.1% of flow
Common Shares
SEC:0001209191-21-064377:0 · 11 Nov 2021
Ideal exit: 8 Aug 2022 (T+270) €110m 5,598,420 shares @ €19.7258 8.84% mcap 97.7% of flow
Common Shares
SEC:0000899243-21-022994 · 9 Jun 2021
€110m 5,598,420 shares @ €19.7258 8.84% mcap 46.4% of flow
Common Shares
SEC:0000899243-21-022994:0 · 9 Jun 2021
About Thermopylae Holdings Ltd. Thermopylae Holdings Ltd. is a director and insider at AbCellera Biologics Inc.